Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three ...

Acadia Pharma’s plan to develop pimavanserin as a treatment for additional indications is in disarray after the drug failed a phase 3 trial in schizophrenia. The company said it doesn’t intend ...

Manly forward Haumole Olakau'atu is facing an extended stint on the sidelines after dislocating his shoulder in his side's loss to the Titans on Friday night. The injury came on a tough night ...

The Ariel Helwani ShowEverything boxing & MMA from the world and mind of Ariel Helwani. The Kevin O'Connor ShowKevin O'Connor talks ball with the best names from around the world of basketball ...

Some people aren’t able to get their Discord GIFs to work, whether on mobile or PC. If you’re among them, keep reading. We’ll show you how to fix this issue so you can get back to expressing yourself ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...